Moy HY - Search Results

1

Elucidating the Phase I metabolism of psilocin in vitro.

Chen J, Wang Z, Yong CY, Goh EML, Moy HY, Chan ECY. Chen J, et al. Among authors: moy hy. Arch Toxicol. 2025 Jan 3. doi: 10.1007/s00204-024-03952-7. Online ahead of print. Arch Toxicol. 2025. PMID: 39751877

2

An Improved GC-MS/MS Method for a Fast Multidrug Analysis in Hair.

Zhang HH, Loh JYH, Moy HY, Lui CP. Zhang HH, et al. Among authors: moy hy. Drug Test Anal. 2024 Dec 14. doi: 10.1002/dta.3840. Online ahead of print. Drug Test Anal. 2024. PMID: 39673283

3

Characterization of iso-LSD metabolism using human liver microsomes in comparison to LSD and its applicability as urinary biomarker for LSD consumption.

Ng XQ, Goh EML, Hamzah A, Yao YJ, Moy HY. Ng XQ, et al. Among authors: moy hy. J Anal Toxicol. 2024 Jun 11;48(5):281-288. doi: 10.1093/jat/bkae023. J Anal Toxicol. 2024. PMID: 38613436

4

Advances in urinary biomarker research of synthetic cannabinoids.

Wang Z, Leow EYQ, Moy HY, Chan ECY. Wang Z, et al. Among authors: moy hy. Adv Clin Chem. 2023;115:1-32. doi: 10.1016/bs.acc.2023.03.004. Epub 2023 Mar 28. Adv Clin Chem. 2023. PMID: 37673518

5

Qualitative Confirmation of 94 New Psychoactive Substances and Metabolites in Urine Using Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry.

Goh EML, Ng XQ, Yong CY, Hamzah A, Moy HY. Goh EML, et al. Among authors: moy hy. J Anal Toxicol. 2023 Apr 14;47(4):366-378. doi: 10.1093/jat/bkad006. J Anal Toxicol. 2023. PMID: 36715077

6

Identification of Optimal Urinary Biomarkers of Synthetic Cannabinoids BZO-HEXOXIZID, BZO-POXIZID, 5F-BZO-POXIZID, and BZO-CHMOXIZID for Illicit Abuse Monitoring.

Lee KZH, Wang Z, Fong CY, Goh EML, Moy HY, Chan ECY. Lee KZH, et al. Among authors: moy hy. Clin Chem. 2022 Nov 3;68(11):1436-1448. doi: 10.1093/clinchem/hvac138. Clin Chem. 2022. PMID: 36175111

7

Transesterification of Indazole-3-carboxamide Synthetic Cannabinoids: Identification of Metabolite Biomarkers for Diagnosing Co-abuse of 5F-MDMB-PINACA and Alcohol.

Wang Z, Fong CY, Goh EML, Moy HY, Chan ECY. Wang Z, et al. Among authors: moy hy. J Anal Toxicol. 2023 Jan 24;46(9):1016-1024. doi: 10.1093/jat/bkab121. J Anal Toxicol. 2023. PMID: 34918103

8

Urinary Metabolite Biomarkers for the Detection of Synthetic Cannabinoid ADB-BUTINACA Abuse.

Sia CH, Wang Z, Goh EML, Tan YL, Fong CY, Moy HY, Chan ECY. Sia CH, et al. Among authors: moy hy. Clin Chem. 2021 Nov 1;67(11):1534-1544. doi: 10.1093/clinchem/hvab134. Clin Chem. 2021. PMID: 34387654

9

Diagnosing intake and rationalizing toxicities associated with 5F-MDMB-PINACA and 4F-MDMB-BINACA abuse.

Lie W, Cheong EJY, Goh EML, Moy HY, Cannaert A, Stove CP, Chan ECY. Lie W, et al. Among authors: moy hy. Arch Toxicol. 2021 Feb;95(2):489-508. doi: 10.1007/s00204-020-02948-3. Epub 2020 Nov 24. Arch Toxicol. 2021. PMID: 33236189

10

Ruthenium(II) complexes in polymerised bicontinuous microemulsions.

Moy HY, Chow PY, Yu WL, Wong KM, Yam VW, Gan LM. Moy HY, et al. Chem Commun (Camb). 2002 May 7;(9):982-3. doi: 10.1039/b200799a. Chem Commun (Camb). 2002. PMID: 12123079

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters